| نویسندگان | Mohammad GhasemiGol |
| نشریه | Journal of cilinical medicine |
| شماره صفحات | 1-26 |
| شماره سریال | 10 |
| شماره مجلد | 16 |
| نوع مقاله | Full Paper |
| تاریخ انتشار | 2021 |
| نوع نشریه | چاپی |
| کشور محل چاپ | ایران |
| نمایه نشریه | ISI،JCR |
| کلید واژه ها | COVID, 19; SARS, CoV, 2; transcriptional profiling; WGCNA; bronchial epithelium cells; treatment; explainable artificial intelligence |
|---|
چکیده مقاله
The coronavirus disease-2019 (COVID-19) pandemic has caused an enormous loss of lives.
Various clinical trials of vaccines and drugs are being conducted worldwide; nevertheless, as of
today, no effective drug exists for COVID-19. The identification of key genes and pathways in this
disease may lead to finding potential drug targets and biomarkers. Here, we applied weighted
gene co-expression network analysis and LIME as an explainable artificial intelligence algorithm to
comprehensively characterize transcriptional changes in bronchial epithelium cells (primary human
lung epithelium (NHBE) and transformed lung alveolar (A549) cells) during severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. Our study detected a network that significantly
correlated to the pathogenicity of COVID-19 infection based on identified hub genes in each cell line
separately. The novel hub gene signature that was detected in our study, including PGLYRP4 and
HEPHL1, may shed light on the pathogenesis of COVID-19, holding promise for future prognostic
and therapeutic approaches. The enrichment analysis of hub genes showed that the most relevant
biological process and KEGG pathways were the type I interferon signaling pathway, IL-17 signaling
pathway, cytokine-mediated signaling pathway, and defense response to virus categories, all of
which play significant roles in restricting viral infection. Moreover, according to the drug–target
network, we identified 17 novel FDA-approved candidate drugs, which could potentially be used to
treat COVID-19 patients through the regulation of four hub genes of the co-expression network. In
conclusion, the aforementioned hub genes might play potential roles in translational medicine and
might become promising therapeutic targets. Further in vitro and in vivo experimental studies are
needed to evaluate the role of these hub genes in COVID-19.
لینک ثابت مقاله